Serum anti-CCNY autoantibody is an independent prognosis indicator for postoperative patients with early-stage nonsmall-cell lung carcinoma.

Dis Markers · 2013 · PMC3789285 · PMID 24167380

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In addition, the present study demonstrates that anti-CCNY autoantibody is associated with poor prognosis for NSCLC, compare with anti CCNY autoantibodies negative patients, the positive patients tended to have shorter survival times although the difference did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.